Immunohistochemical Expression of p16, p21, p27 and Cyclin D1 in Oral Nevi and Melanoma
- 5 February 2012
- journal article
- research article
- Published by Springer Nature in Head and Neck Pathology
- Vol. 6 (3) , 297-304
Abstract
The acquisition of abnormalities at G1/S is considered a crucial step in the genesis and progression of melanoma. The expression of cell cycle regulators has also been used in various neoplasms as an adjunct to diagnosis. The aim of this study was to compare the expression of p16, p21, p27 and cyclin D1 in oral nevi and melanomas. Expression of these cell cycle regulatory proteins was evaluated by immunohistochemistry in 51 oral melanocytic lesions, including 38 intramucosal nevi and 13 primary oral melanomas. p16 and p27 were highly expressed in intramucosal nevi, whereas p21 and cyclin D1 expression was higher in oral melanomas. The results indicate that p21 and cyclin D1 may be involved in the development of oral melanomas, and eventually they may be useful in the differential diagnoses of oral benign and malignant melanocytic lesions.Keywords
This publication has 29 references indexed in Scilit:
- NRAS and BRAF mutation frequency in primary oral mucosal melanomaOncology Reports, 2011
- Cell cycle and apoptosis regulators in Spitz nevi: Comparison with melanomas and common neviJournal of the American Academy of Dermatology, 2007
- Downregulation of cell cycle modulators p21, p27, p53, Rb and proapoptotic Bcl‐2‐related proteins Bax and Bak in cutaneous melanoma is associated with worse patient prognosis: preliminary findingsJournal of Cutaneous Pathology, 2007
- Cutaneous Melanoma Subtypes Show Different BRAF and NRAS Mutation FrequenciesClinical Cancer Research, 2006
- Skp2 and p27kip1 expression in melanocytic nevi and melanoma: an inverse relationship*Journal of Cutaneous Pathology, 2004
- Abnormal cell cycle regulation in primary human uveal melanoma culturesJournal of Cellular Biochemistry, 2004
- Expression of cell cycle inhibitor p27Kip1 and its inactivator Jab1 in melanocytic lesionsLaboratory Investigation, 2004
- Expression of Rb, pRb2/p130, p53, and p16 proteins in malignant melanoma of oral mucosaOral Oncology, 2001
- Protein Expression of the Cell-Cycle Inhibitor p27Kip1 in Malignant MelanomaThe American Journal of Pathology, 1998
- Expression of the Tumor Suppressor Gene Product p16INK4 in Benign and Malignant Melanocytic LesionsJournal of Investigative Dermatology, 1998